BIOCRYST PHARMACEUTICALS, INC. (BCRX) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

Loading BCRX…

BIOCRYST PHARMACEUTICALS, INC. (BCRX) | Jive Data

Google Sheets Add-onSheets Account

Profile Financials SEC Filings Insider Transactions Ownership

SEC filing

BIOCRYST PHARMACEUTICALS, INC.

BCRX · CIK 882796

4 · Sep 2, 2026 · Director Frank Steven was granted 1,288 shares at $9.70/share ($12,494)

4

Director Frank Steven was granted 1,288 shares at $9.70/share ($12,494)

Filed: Sep 2, 2026
Period: Aug 31, 2026
Accession: 0000882796-26-000057
Filer: BIOCRYST PHARMACEUTICALS INC

View on SEC.gov All SEC filings

Filing document

PRIMARY DOCUMENT

xslF345X06/form4.xmlSEC.gov

Other files

Graphics and non-inline formats (not embedded below).

4PRIMARY DOCUMENTform4.xml
Open SEC.gov